objectives In June 2015, Partners in Health (PIH) and the Liberian Ministry of Health began a community health worker (CHW) programme containing food support, reimbursement of transport and social assistance to address gaps in tuberculosis (TB) treatment exacerbated by the 2014-2015 Ebola virus disease (EVD) epidemic. The purpose of this article was to analyse the performance of routine clinical TB care and the effects of this CHW programme.
Introduction
Per the 2016 WHO global TB report, Liberia is a highburden TB country, with an estimated TB incidence of 308 per 100 000 population per year, and with only 42% estimated case detection coverage relative to incident cases [1] . There is an estimated 16% national treatment default rate [1] . The 2014-2015 Ebola virus disease (EVD) outbreak exacerbated the situation [2] [3] [4] [5] [6] , causing an estimated 11 533 additional TB-related deaths in Liberia (compared with 4769 deaths directly from EVD) as modelled using decision trees by Parpia et al. [6] . To address the large burden of TB in Liberia, great strides need to be made in strengthening a health system still recovering from a prolonged civil crisis [7] .
In 2014, Liberia displayed some of the poorest outcomes in the region regarding TB care and treatment [1] . Cote d'Ivoire, Guinea and Sierra Leone-Liberia's neighbours-each achieved higher treatment success, with 78.9%, 82.5% and 85.1%, respectively, than Liberia with 74.4%. Liberia also exhibited a much higher lost-tofollow-up (LTFU) rate of 15.9% than the 6.5%, 5.7% and 7.6% in Cote d'Ivoire, Guinea and Sierra Leone, respectively. Systematic reviews have found that significant drops in the TB care cascade most often occur between the time a patient is diagnosed with TB and enrolment into care (an estimated 30.7% of those intended for screening), or between enrolment into care and the ultimate completion of treatment (an estimated 18.8% of those intended for screening) [8] . These reviews of TB treatment adherence interventions rank cash reimbursements and CHW directly observed treatment, short-course (DOTS) as two of the top four interventions in strengthening health systems (the other two being staff training and health worker DOTS) [9] .
In other civil conflict settings, TB LTFU rates have been reduced from 13% prior to DOTS-based treatment with CHWs to only 3% post-intervention [10] . In other low-and middle-income country (LMIC) settings-albeit without the use of CHWs-LTFU after the onset of DOTS-based treatment fell from 16.3% to 1.4% in Guangzhou, China [11] , and from 16.8% to 5.9% in southern Ethiopia [12] .
In this article, we aimed to provide detailed analyses of the performance of TB treatment outcomes in MOH clinics in the rural south-east region of Liberia in the wake of the EVD crisis and the implementation of a CHW intervention at these clinics, instituted as the epidemic reached its expiration and the cases had dwindled to the single digits. These detailed analyses can identify gaps in care pathways and prioritise future systems strengthening interventions. We anticipate these analyses to be of interest to researchers, implementers and policymakers as they consider optimal health system, implementation science and operational research systems strengthening interventions in LMIC countries such as Liberia. At the time of implementation of the CHW intervention, the EVD crisis had largely ended. According to the WHO's situation report of the week of 3 June 2015, there had been 10 666 confirmed, probable or suspected cases, with 4806 reported deaths from this group, compared with an ultimate number of 10 675 such cases and 4809 deaths by the end of the crisis [13] . The areas of the CHW intervention were largely untouched by the worst of the crisis, with the intervention counties of Grand Gedeh and Maryland experiencing only 11 confirmed or probable cases (four in Grand Gedeh and seven in Maryland).
Methods

Study setting
Intervention description
Frequently during the year, and most pointedly during the rainy season months of May through November, the roads spanning these two counties can become impassable, causing severe disruptions to the flow of drugs and medical supplies from Monrovia, the capital, to this region. To comprehensively strengthen the health systems of these counties, PIH and the CHTs designed a community health worker (CHW) programme that operates in tandem with the TB treatment support already offered at the health facilities in these counties.
A total of 118 CHWs were recruited in three waves (May 2015, August 2015 and March 2016) and received a 10-day training. The baseline training programme included the following: modules about their role in the health system, the mission to fight HIV, TB and leprosy nationally, training on TB prevention, transmission and treatment, health system referrals, counselling skills and psychosocial first aid, motivational interviewing to elicit behaviour change and TB household contact tracing. CHWs were supervised by CHW peer supervisors and clinical supervisors. Literacy tests were not conducted during any phase of CHW recruitment.
The CHW responsibilities and services included the following: (i) regular home visits of assigned TB patients for medication adherence support; (ii) psychosocial support; (iii) recognition and referral of danger signs related to the patient's treatment; (iv) patient education; (v) TB household contact tracing which includes tracing LTFU/defaulted patients assigned to each CHW monthly by the clinical supervisors; and (vi) limited work at the health facility focused on tasks related to the TB patient pathway. CHWs are paid a baseline monthly salary, with a variable component based on their performance.
The intervention had a socio-economic assistance programme directed to the TB patient, with food support, transport reimbursement and additional social support provided if deemed necessary. Table 1 describes in detail the main components of the intervention and the standard of care for TB in Liberia.
Data sources and patient eligibility
Study data sources included the TB registers installed by the National TB and Leprosy Control Program of the MOH.
The patients' records contained within these registers signify the totality of the patients under TB care and treatment in Grand Gedeh and Maryland Counties as recognised by the MOH. That included patients initiating pulmonary and extra-pulmonary TB treatment between January 2015 and February 2017. All available information in the MOH registries was collected. Patients were excluded in the following cases: they were 'transferred in', from another treatment facility; or they were 'lost to follow-up and returned by community health worker', when they were excluded because the date of treatment initiation could not 
Intervention
Integrated system of CHW responsibilities Community outreach activities Regular home visitation of assigned patients. Services provided by the CHW include the following: medication adherence support; psychosocial support; recognition and referral of danger signs related to the patient's treatment; patient education; and TB household contact tracing. Tracing LTFU/defaulted patients assigned to each CHW monthly by the Clinical Supervisors Community referrals are used to serve as a tool for more general health issues and can be made for conditions outside of suspected HIV/TB/LP cases. Health education radio broadcasts conducted two times per week, and visits to local schools Community outreach for rural communities visits two times per week for communities whose residents have greater difficulty accessing health facility care due to long distances. Health services delivery at the Facility Level Responsibilities consist of aiding patient navigation between clinic, laboratory and pharmacy at their monthly appointments; relationship building between health facility staff and community; administrative support within the TB and ART clinics. Secondary responsibilities address health workforce shortage. Ex: support laboratory capacity, triage, patient registration and infant immunisations following on-site trainings. Socio-economic Assistance Programme to Patients with TB Food support Monthly food parcels for the duration of their course of treatment (pulmonary, extra-pulmonary or MDR-TB). The parcel contains 25 kg of rice; 5 kg of beans; 2 litres of vegetable oil; and 5 tins of sardines.
Transport reimbursement
For full transportation reimbursement on a monthly basis to attend their monthly clinical appointments; reimbursement is distributed regardless of distance from the facility and calculated based on the amount of motorbike gasoline required.
Social assistance
Evaluation and verification of additional needs are conducted and provided for on a case-by-case basis. Rental assistance, school fees and additional nutritional support are prioritised.
Chemotherapy for TB, rifampin (R), isoniazid (H), pyrazinamide (Z) and ethambutol (E).
be ascertained. We also excluded newly diagnosed patients that where cured or completed the treatment with an improbable duration of treatment (less than 120 days).
Covariates
Age, sex and date of treatment initiation/continuation were assessed at baseline.
Outcomes
Patients were considered 'cured' if they tested smear-positive at diagnosis and smear-negative upon treatment completion, and 'treatment success' if they completed treatment with clinical improvement but no smear done, were unable to produce a working sputum sample, or had a negative sputum smear initially yet received a diagnosis based on clinical signs and symptoms. These two outcomes were aggregated as a measure of positive outcomes, although we present the results separately as well. 'Treatment failure' outcomes signified completing treatment but testing smearpositive. Date of cure or treatment completion was decided by the clinical supervisor. Deaths and transfers out were confirmed by the clinical supervisor of the facility's chest clinic; if a patient otherwise went missing for some unknown reason, she/he was classified as LTFU. The date of death or the last visit to the clinic was considered the end date for these patients. For the purposes of this study, the number of days from initiation of treatment until a potential outcome was used as the primary time measure.
Statistical analyses
We compared the baseline characteristics age, sex and treatment health facility by before and after the intervention. Categorical and binary variables were compared using chi-square test, while continuous variables were compared using t-tests. Age was categorised as 0-15, 16-25, 26-35, 36-45, 46-55, >55, and tested for nonlinearity. We assumed that the different outcomes of TB treatment could be considered a competing risks because the occurrence of an outcome of interest could be precluded by another [14, 15] . All the above described outcomes were considered competing risks; hence, we used competingrisks survival analysis controlling for patient clustering at the clinic level. These analyses result in cause-specific cumulative incidence curves and subhazard functions for the failure events of interest. Models were run separately for cured, treatment completion, LTFU and death as the failure event of primary interest, considering other events as competing risks. We did not run models separately for treatment failure due to the small numbers of events.
Similarly, transferring to another clinic was also not considered an outcome of primary interest. The proportional hazards assumption was evaluated visually and graphically using Schoenfeld residuals [16] . All analyses were conducted in Stata 14 using a two-sided alpha value of 0.05.
Ethics
This study was approved by the University of Liberia institutional review board.
Results
The initial data set of our study had a total of 674 patients representing all patients with TB admitted to the study facilities between January 2015 and April 2017. From these, 106 patients (15.7%) were excluded at baseline because their date of treatment initiation could not be ascertained. Another eight patients (1.2%) were excluded due to abnormally small treatment duration. Our final sample had 560 patients, 89 in the pre-intervention group and 471 in the post-intervention group; 84.1% of patients started TB treatment after the CHW intervention, which was also after the conclusion of the Ebola outbreak (June 2015), while the other 15.8% initiated between January 2015 and May 2015, which was during the outbreak and before the CHW intervention. Table 2 highlights the baseline characteristics pre-and post-intervention. The two groups were well balanced regarding age groups (P = 0.09) and sex distribution (P = 0.87). The largest number of patients was seen at JJ Dossen Hospital (44%), followed by Martha Tubman Hospital (25%), and Pleebo Health Center (21%). In terms of overall patient outcomes, the cured proportions are similar, with 29.2% pre-intervention and 29.3% post-intervention. However, treatment completed with positive clinical outcomes, but no smear confirmation was notably more common in the post-intervention group with 46.9% post-intervention vs. 32.6%, pre-intervention. Importantly, the post-intervention group had a smaller proportion of LTFU, with 3.4% post-intervention vs. 14.6% preintervention. Comparing the two groups, a similar proportion of cases transferred out (approximately 10%).
TB treatment death rates
In the unadjusted analyses, there is a 35% lower subhazard of death in the post-intervention group vs. pre-intervention, although this association did not reach significance in either the adjusted or unadjusted models (Table 3 ; Figure 1) . More specifically, death rates at 100 days before June 2015 were 10.3%, vs. 6.1% after June 2015. We observed a 25% reduction in the sHR of death for females vs. males adjusted for age and intervention group, with the true sHR reduction for female TB patients estimated between 12% and 36% (sHR: 0.75; CI: 0.64, 0.88).
TB treatment LTFU rates
In both unadjusted and adjusted models (Tables 3 and  4) , LTFU rates were significantly lower. Adjusted for age and sex, the post-intervention group had a 76% reduction in LTFU subhazard ratio. (sHR: 0.24; CI: 0.14, 0.39); ( Table 4 ). The cumulative incidence of LTFU at 100 days was 9.3% pre-intervention and 1.0% postintervention ( Figure 2 ). There were no significant differences between LTFU rates by gender. Older patientsthose over 55-had a 7.2 times higher subhazard than the patients in the reference group, those younger than 15 years, adjusted for sex and intervention group (sHR: 7.2; CI: 1.75, 28.7) ( Table 4 ). Other age groups had a higher subhazard ratio of LTFU, that is those 16-25 years old and those 36-45 years old, although there was not a defined trend across age groups. 
TB treatment cured (smear negative) rates
There were no significant differences in cured rates comparing before and after the intervention. Females were more likely to be cured than males, although this observed point estimate difference was not statistically significant (sHR: 1.17: CI: 0.89, 1.55). Adult patients (>15 years old) had consistently higher subhazard ratios for cure (negative smear) than the reference group (<15 years old). This difference likely at least partially reflects the inability of younger patients to produce a working sputum sample (Tables 3 and 4) .
TB treatment completion (no smear) rates
Treatment completion rates without a smear were 60% higher post-intervention in unadjusted models (sHR: 1.6; CI: 1.08, 2.39), although this association became barely significant after adjustment for age and sex (sHR: 1.53; CI: 1.00, 2.39). Adult patients (>15 years old) had significantly lower treatment completion rates without a smear than children (<15 years old), likely due to the reason evoked in the previous paragraph.
Discussion
These analyses demonstrate a statistically significant reduction in LTFU rates between the TB treatment populations before and after the end of EVD in Liberia and the onset of a CHW patient accompaniment, transport reimbursement and food support programme. Overall, only 16 of 471 registered patients, or 3.4%, were LTFU after June 2015, whereas 13 of 89 registered patients, or 14.6%, were LTFU in the 5 months prior to June 2015. These results closely mirror those illustrated elsewherefor instance, a decrease in LTFU rates from 13% to 2.8% in a post-conflict setting in Churachandpur District, India [10] , or a reduction in LTFU from 16.8% to 5.9% in southern Ethiopia [12] . However, these analyses did not show a significant effect on death rates. Despite an overall reduction in death rates from 13.4% to 8.7%, this observed reduction was not statistically significant and is higher than the 2.8%, 2.6% and 8.5% death rates that have been observed in other LMIC settings [10] [11] [12] . Given the low HIV prevalence in rural Liberia, it is unclear why the death rate at these health facilities was so high initially. The consistent drug supply problems during the 6-month rainy season might explain this higher rate of death. Alternatively, a death of trained health facility professionals and lack of public awareness concerning TB may drive poor adherence and result in higher death rates.
Although the overall treatment success rate-measured as treatment completions plus cures-rose from 61.8% to 77.2%, the cure rate remained stagnant before and after the intervention, from 29.2% to 29.3%. Again, diagnostic capacity, supply-chain stock outs of essential TB meds and diagnostic reagents, and a lack of healthcare workers may contribute to this low cure rate, as the ability to perform confirmatory smear tests is considerably hampered by these detriments. Accordingly, fluctuations in the cure rates-despite steady or improving treatment success rates-are not uncommon: in southern Ethiopia [12] , cures increased from 1.6% to 31.4%, while overall treatment success only increased from 80.5% to 84.8%; while conversely, in Guangzhou, China [11] , cure rates decreased from 52.1% to 36.5%, while the treatment success rate increased from 75.7% to 85.7%. It is important to consider the array of challenges associated with TB care in the south-east region of Liberia. Liberia is only 12 years removed from 14 years of civil conflict which devastated an already weak health system. In addition, Liberia recently emerged from the worst EVD epidemic known to date [2, [17] [18] [19] [20] [21] . Our findings that an 76% reduction in LTFU rates can be obtained over a relatively short time period immediately after the EVD outbreak is a testament to the strength of CHW interventions, and their potential for positive impacts on TB care and treatment. However, readers must keep in mind that our analyses are confounded with the end of the Ebola outbreak, which could account for some of the decreases in LTFU. With a combination of civil, infrastructural and health challenges, the south-east region of Liberia occupies a unique space in the literature with regards to TB treatment environments, and it is encouraging that even a non-DOTS community health work programme can contribute to such positive results that closely mirror the results seen with DOTS-based programmes. A 2015 review of the effectiveness of DOTS care provided by a number of different providers including family members, CHWs and clinicians in a variety of settings found no significant improvement in successful completion of TB treatment compared with those who self-administered anti-TB medications [22] . The review did, however, show slightly better outcomes if patients had contact with clinic or clinical personnel more than once a month. The CHW accompaniment model in our study could support this use of CHWs as treatment supporters in a non-DOTS model. A review of the economic impact of tuberculosis for patients in sub-Saharan Africa found that the costs associated with TB treatment can be 'catastrophic' with costs averaging 10% of people's monthly income. These costs can influence health seeking behaviour and be a factor in LTFU [23] . In the two counties of our study in Liberia, patients can pay up to $35 USD in transportation fees for one visit to a TB treatment site which alone is a 'catastrophic' expense in a region where many people are unemployed or survive primarily on subsistence farming. As stated previously, our CHW intervention included psychosocial support from CHW visits three times a week in addition to a monthly food package, and transportation reimbursement for clinic appointments. A study in India showed that patients who received monthly food rations had a 50% lower risk of unsuccessful treatment outcomes than those who received no food support [24] . Another study showed that patients who receive socio-economic support are more likely to complete treatment and be 'cured' and less likely to incur catastrophic costs [25] . Thus, in our study transportation reimbursement and nutritional support could be important factors contributing to improved outcomes during the CHW intervention.
Although the difference in outcomes between pre-and post-June 2015 patients was the starkest observation from the analysis, other patterns emerged that bear mentioning. Younger patients were less likely to be smear-negative. This difference is likely due to the inability of younger patients to produce sputum and argues for innovative approaches to diagnosing younger TB patients, especially using new technologies such as GeneXpert which can diagnose TB using diagnostic samples other than sputum. We found that older patients-those over 55-are more likely to become LTFU than their younger counterparts, as has been observed in Ethiopia and China [11, 12] . It is not clear as to why it is more difficult for older patients to achieve positive outcomes, and more detailed investigations into the drivers of LTFU outcomes will ideally reveal this difference amongst age groups. One possible explanation could be difficulties in transport, which could impose a particular toll on older patients. We also observed slightly lower (although not statistically significant) death rates in female patients, which aligns with what has been observed in previous studies in China and India [10, 11] .
A key limitation of these findings is that our pre-vs. post-intervention comparison is confounded by the EVD epidemic. However, we note that the incidence of EVD cases in Maryland County (the site for this study) was very low throughout the outbreak. According to the WHO, there were only three confirmed cases of EVD in Maryland County. The limited spread of EVD in this area could decrease the concerns that EVD had a strong confounding effect on the present analyses. We also have included patients with TB from a relatively small number of clinics in one area of Liberia; thus, we cannot generalise these findings to similar CHW programmes implemented in other areas of the country. Due to confidentiality considerations, patients' HIV status was not known; it is possible that this additional information might offer some insights into the unexplained death and LTFU patterns described above. This study also had a number of notable strengths. We included all patients enrolled in TB treatment across a census of facilities providing TB care in the regions of interest. Our study also spanned a number of years, includes a relatively large sample of patients and provides a very granular look at the true pragmatic effectiveness of TB treatment outcomes in the real-world rural Liberian setting.
Overall, our study shows that CHW accompaniment, nutritional assistance and cash reimbursement for travel can be crucial contributors to improving rates of LTFU even in a low-resource, rural, post-EVD and post-conflict setting. Furthermore, our study suggests that large improvements in rates of LTFU, and potentially death rates, are possible even in the absence of strict DOTSbased treatment protocols which can require significantly more human resources.
